Back to Search
Start Over
104 PD-1 Inhibition with Nivolumab Can Cure EBV-driven Lymphoproliferative Disorders, Avoiding Need for Toxic Allogeneic Bone Marrow Transplantation.
- Source :
-
Clinical Immunology . 2024 Supplement, Vol. 262, pN.PAG-N.PAG. 1p. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15216616
- Volume :
- 262
- Database :
- Academic Search Index
- Journal :
- Clinical Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 176784708
- Full Text :
- https://doi.org/10.1016/j.clim.2024.110046